This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Onureg, azacitidine, D...
Basilea Pharmaceutica has cited its “stringent risk-return criteria” as a reason...
“A decade ago this past June, my sister died at the National Institutes of Healt...
The uncertainty around the spending freeze was an epiphany for some, a realizati...
XRHealth is acquiring RealizedCare, a company that couples immersive experiences...
Onureg : EPAR - Procedural steps taken and scientific information after the auth...
European Medicines Agency’s data protection notice regarding personal data proce...
EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9...
Human medicines European public assessment report (EPAR): Azacitidine Accord, az...
ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicin...
Programme - EMA's Open Door Day
Agenda - ACT EU workshop on ICH E6 (R3)
February 14, 2025 -- Today, the U.S. Food and Drug Administration approved Meril...
STAT is backing up and monitoring CDC data in real time: See what's changing.
INCHEON, Korea – Feb 16, 2025 – Samsung Bioepis Co., Ltd. today announced that t...
"Read this email immediately” That was the subject line of emails that landed in...
Wed, Feb 12, 2025 -- The FDA has granted Fast Track Designation to Lundbeck’s in...
At the AAAS annual meeting, "anger, uncertainty, and anxiety" about the future o...
Members of the CDC's Epidemic Intelligence Service were warned Friday that many ...
PHOENIXVILLE, Pa., Feb. 13, 2025 /PRNewswire/ -- PleoPharma, Inc., a privately h...
February 17, 2025 -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Inna...
The Trump administration is set to eliminate thousands of federal health care jo...